Compare ADMA & NGVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADMA | NGVT |
|---|---|---|
| Founded | 2004 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.6B |
| IPO Year | 2012 | 2015 |
| Metric | ADMA | NGVT |
|---|---|---|
| Price | $7.92 | $68.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $25.67 | ★ $72.50 |
| AVG Volume (30 Days) | ★ 6.0M | 219.6K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.10 |
| EPS | 0.19 | ★ 1.66 |
| Revenue | $42,219,783.00 | ★ $1,167,600,000.00 |
| Revenue This Year | $27.46 | $3.63 |
| Revenue Next Year | $22.11 | $0.50 |
| P/E Ratio | $43.03 | ★ $41.42 |
| Revenue Growth | ★ 43.85 | N/A |
| 52 Week Low | $7.21 | $39.74 |
| 52 Week High | $22.37 | $79.29 |
| Indicator | ADMA | NGVT |
|---|---|---|
| Relative Strength Index (RSI) | 30.12 | 45.38 |
| Support Level | $7.34 | $63.60 |
| Resistance Level | $16.02 | $77.72 |
| Average True Range (ATR) | 0.44 | 2.09 |
| MACD | 0.02 | -0.47 |
| Stochastic Oscillator | 30.69 | 37.53 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.